ImmunologybioRxivPreprint
Disabling a key viral innate immunity antagonist converts measles vaccine into RIG-I-driven cancer immunotherapy
Aleksandr Barinov, Heidy Vera-Peralta, Joëlle S. Nader…·Frédéric Tangy
This paper modifies a measles vaccine by removing a viral protein to create a cancer immunotherapy that activates the immune system via RIG-I signaling, leading to tumor regression in multiple models.